Real-World Effectiveness of Nirmatrelvir/Ritonavir and Dexamethasone Among Hospitalized Patients with COVID-19: A Prospective Cohort Study.

Infection and drug resistance(2023)

引用 0|浏览2
暂无评分
摘要
Combination therapy of N/R and dexamethasone increased negative conversion of NAAT and was associated with a non-significant improvement in clinical recovery. Further studies are warranted to confirm this efficacy.
更多
查看译文
关键词
nirmatrelvir/ritonavir,hospitalized patients,dexamethasone,nirmatrelvir/ritonavir,prospective cohort study,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要